PVL Staphylococcus aureus Clinical Guide<\/title>\n <style>\n * {\n margin: 0;\n padding: 0;\n box-sizing: border-box;\n }\n\n body {\n font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\n line-height: 1.6;\n color: #333;\n background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);\n min-height: 100vh;\n }\n\n .container {\n max-width: 1200px;\n margin: 0 auto;\n padding: 20px;\n }\n\n .header {\n background: white;\n border-radius: 15px;\n padding: 30px;\n margin-bottom: 30px;\n box-shadow: 0 10px 30px rgba(0,0,0,0.1);\n text-align: center;\n }\n\n .header h1 {\n color: #2c3e50;\n font-size: 2.5em;\n margin-bottom: 10px;\n }\n\n .stat-box {\n background: #e74c3c;\n color: white;\n padding: 15px;\n border-radius: 10px;\n margin: 20px 0;\n font-weight: bold;\n text-align: center;\n }\n\n .nav-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));\n gap: 20px;\n margin-bottom: 30px;\n }\n\n .nav-card {\n background: white;\n border-radius: 12px;\n padding: 25px;\n cursor: pointer;\n transition: all 0.3s ease;\n box-shadow: 0 5px 15px rgba(0,0,0,0.1);\n border-left: 5px solid #3498db;\n }\n\n .nav-card:hover {\n transform: translateY(-5px);\n box-shadow: 0 15px 30px rgba(0,0,0,0.2);\n border-left-color: #e74c3c;\n }\n\n .nav-card h3 {\n color: #2c3e50;\n margin-bottom: 10px;\n font-size: 1.3em;\n }\n\n .nav-card p {\n color: #7f8c8d;\n font-size: 0.9em;\n }\n\n .content-section {\n display: none;\n background: white;\n border-radius: 15px;\n padding: 30px;\n margin-bottom: 20px;\n box-shadow: 0 10px 30px rgba(0,0,0,0.1);\n animation: fadeIn 0.5s ease-in;\n }\n\n .content-section.active {\n display: block;\n }\n\n @keyframes fadeIn {\n from { opacity: 0; transform: translateY(20px); }\n to { opacity: 1; transform: translateY(0); }\n }\n\n .section-title {\n color: #2c3e50;\n font-size: 2em;\n margin-bottom: 20px;\n border-bottom: 3px solid #3498db;\n padding-bottom: 10px;\n }\n\n .risk-factors {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));\n gap: 15px;\n margin: 20px 0;\n }\n\n .risk-factor {\n background: #f8f9fa;\n padding: 15px;\n border-radius: 8px;\n border-left: 4px solid #e74c3c;\n }\n\n .risk-factor h4 {\n color: #e74c3c;\n margin-bottom: 5px;\n }\n\n .clinical-features {\n display: grid;\n grid-template-columns: 1fr 1fr;\n gap: 25px;\n margin: 20px 0;\n }\n\n .feature-box {\n background: #ecf0f1;\n padding: 20px;\n border-radius: 10px;\n border-top: 4px solid #3498db;\n }\n\n .feature-box h4 {\n color: #2c3e50;\n margin-bottom: 15px;\n font-size: 1.2em;\n }\n\n .treatment-table {\n width: 100%;\n border-collapse: collapse;\n margin: 20px 0;\n background: white;\n border-radius: 8px;\n overflow: hidden;\n box-shadow: 0 5px 15px rgba(0,0,0,0.1);\n }\n\n .treatment-table th {\n background: #3498db;\n color: white;\n padding: 15px;\n text-align: left;\n }\n\n .treatment-table td {\n padding: 12px 15px;\n border-bottom: 1px solid #ecf0f1;\n }\n\n .treatment-table tr:nth-child(even) {\n background: #f8f9fa;\n }\n\n .alert-box {\n background: #fff3cd;\n border: 1px solid #ffeaa7;\n border-radius: 8px;\n padding: 15px;\n margin: 15px 0;\n border-left: 4px solid #f39c12;\n color: #333;\n }\n\n .alert-box.danger {\n background: #f8d7da;\n border-color: #f5c6cb;\n border-left-color: #e74c3c;\n }\n\n .alert-box.success {\n background: #d4edda;\n border-color: #c3e6cb;\n border-left-color: #27ae60;\n }\n\n .back-btn {\n background: #3498db;\n color: white;\n border: none;\n padding: 12px 25px;\n border-radius: 25px;\n cursor: pointer;\n font-size: 1em;\n margin-bottom: 20px;\n transition: all 0.3s ease;\n }\n\n .back-btn:hover {\n background: #2980b9;\n transform: translateY(-2px);\n }\n\n .highlight {\n background: #fff3cd;\n padding: 2px 6px;\n border-radius: 4px;\n font-weight: bold;\n }\n\n .dosage {\n background: #e8f5e8;\n padding: 10px;\n border-radius: 5px;\n margin: 10px 0;\n border-left: 4px solid #27ae60;\n }\n\n ul, ol {\n margin: 15px 0;\n padding-left: 25px;\n }\n\n li {\n margin: 8px 0;\n }\n\n @media (max-width: 768px) {\n .clinical-features {\n grid-template-columns: 1fr;\n }\n \n .nav-grid {\n grid-template-columns: 1fr;\n }\n \n .header h1 {\n font-size: 2em;\n }\n }\n <\/style>\n<\/head>\n<body>\n <div class=\"container\">\n \n <div class=\"header\">\n <p>Clinical Guide for Diagnosis and Management<\/p>\n <div class=\"stat-box\">\n In the UK, PVL genes are carried by < 2% of clinical S. aureus isolates\n <\/div>\n <\/div>\n\n \n <div id=\"navigation\" class=\"nav-grid\">\n <div class=\"nav-card\" onclick=\"showSection('clinical-features')\">\n <h3>\ud83d\udd0d Clinical Features<\/h3>\n <p>Recognize skin\/soft tissue infections and invasive disease presentations<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('risk-factors')\">\n <h3>\u26a0\ufe0f Risk Factors<\/h3>\n <p>5C model and high-risk populations and settings<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('testing')\">\n <h3>\ud83e\uddea Testing & Diagnosis<\/h3>\n <p>Sample collection, processing, and PVL testing protocols<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('pneumonia')\">\n <h3>\ud83e\udec1 Pneumonia Management<\/h3>\n <p>Necrotising pneumonia recognition and treatment protocols<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('ssti')\">\n <h3>\ud83e\ude79 SSTI Management<\/h3>\n <p>Skin and soft tissue infection treatment guidelines<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('osteomyelitis')\">\n <h3>\ud83e\uddb4 Osteomyelitis<\/h3>\n <p>Deep-seated infection management and treatment options<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('infection-control')\">\n <h3>\ud83d\udee1\ufe0f Infection Control<\/h3>\n <p>PPE requirements, isolation, and outbreak management<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('staff-management')\">\n <h3>\ud83d\udc68\u200d\u2695\ufe0f Staff Management<\/h3>\n <p>Healthcare worker screening, decolonisation, and return-to-work<\/p>\n <\/div>\n <\/div>\n\n \n <div id=\"clinical-features\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Clinical Features of PVL-SA<\/h2>\n \n <div class=\"clinical-features\">\n <div class=\"feature-box\">\n <h4>Skin and Soft Tissue Infections<\/h4>\n <ul>\n <li><strong>Suspect when:<\/strong> Recurrent skin and soft tissue infections<\/li>\n <li>Purulent eye infections<\/li>\n <li>Variable size lesions with\/without necrosis<\/li>\n <li><span class=\"highlight\">Pain disproportionate to appearance<\/span><\/li>\n <li>Multiple cases in close contact settings<\/li>\n <\/ul>\n <\/div>\n \n <div class=\"feature-box\">\n <h4>Invasive Infections<\/h4>\n <ul>\n <li><strong>Necrotising pneumonia<\/strong> – may follow flu-like symptoms<\/li>\n <li>Necrotising fasciitis<\/li>\n <li>Purpura fulminans<\/li>\n <li>Acute haematogenous osteomyelitis<\/li>\n <li>Osteoarticular infections in children<\/li>\n <li>Pyomyositis<\/li>\n <\/ul>\n <\/div>\n <\/div>\n\n <div class=\"alert-box danger\">\n <strong>Key Clinical Signs:<\/strong> Haemoptysis and elevated inflammatory markers may accompany necrotising pneumonia\n <\/div>\n <\/div>\n\n \n <div id=\"risk-factors\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Risk Factors for PVL-SA<\/h2>\n \n <div class=\"alert-box\">\n <strong>Remember the 5C Model:<\/strong>\n <\/div>\n \n <div class=\"risk-factors\">\n <div class=\"risk-factor\">\n <h4>Contaminated items<\/h4>\n <p>Shared towels, equipment<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>Close contact<\/h4>\n <p>Direct person-to-person contact<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>Crowding<\/h4>\n <p>Overcrowded living conditions<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>(Lack of) Cleanliness<\/h4>\n <p>Poor hygiene practices<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>Cuts<\/h4>\n <p>Compromised skin integrity<\/p>\n <\/div>\n <\/div>\n\n <h3>High-Risk Settings<\/h3>\n <ul>\n <li>Households<\/li>\n <li>Close contact sports (wrestling, American football, rugby, judo)<\/li>\n <li>Military training camps<\/li>\n <li>Gyms<\/li>\n <li>Prisons<\/li>\n <\/ul>\n\n <div class=\"alert-box success\">\n <strong>Typical Patient Profile:<\/strong> Young, healthy people, students, athletes, and military personnel with no significant medical history\n <\/div>\n <\/div>\n\n \n <div id=\"testing\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Testing for PVL<\/h2>\n \n <h3>Sample Collection<\/h3>\n <ul>\n <li>Wound swab or pus for skin\/soft tissue infections<\/li>\n <li>Sputum\/BAL for respiratory infections<\/li>\n <li>Blood culture for systemic infections<\/li>\n <li>Process samples as per national SMI<\/li>\n <\/ul>\n\n <div class=\"alert-box\">\n <strong>Clinical Hint:<\/strong> If isolate is MRSA and ciprofloxacin sensitive, higher chance of being PVL positive\n <\/div>\n\n <h3>PVL Testing Process<\/h3>\n <ol>\n <li>Grow Staphylococcus aureus from sample<\/li>\n <li>Send isolate to reference laboratory for PVL test<\/li>\n <li>Results guide treatment decisions<\/li>\n <\/ol>\n\n <h3>Outbreak Investigation<\/h3>\n <table class=\"treatment-table\">\n <tr>\n <th>Outbreak Type<\/th>\n <th>Screening Medium<\/th>\n <th>Notes<\/th>\n <\/tr>\n <tr>\n <td>PVL MSSA<\/td>\n <td>Non-selective agar (blood agar)<\/td>\n <td>Standard screening approach<\/td>\n <\/tr>\n <tr>\n <td>PVL MRSA<\/td>\n <td>Selective medium (Mannitol Salt Agar, chromogenic media)<\/td>\n <td>Do NOT use ciprofloxacin for MRSA selection<\/td>\n <\/tr>\n <\/table>\n <\/div>\n\n \n <div id=\"pneumonia\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing PVL Pneumonia<\/h2>\n \n <div class=\"alert-box danger\">\n <strong>Initial Management:<\/strong> Start treatment as per NICE CAP guidelines (NOT the old PVL guideline recommendations)\n <\/div>\n\n <h3>Clinical Suspicion Criteria<\/h3>\n <ul>\n <li>Multilobular infiltrates<\/li>\n <li>Respiratory rate >30, Pulse rate >140<\/li>\n <li>Haemoptysis<\/li>\n <li>Leukopenia \u00b1 skin and soft tissue infection<\/li>\n <li>Young patient<\/li>\n <li>Recent flu-like illness or close contact<\/li>\n <li>High inflammatory markers, raised CK (pyomyositis)<\/li>\n <\/ul>\n\n <h3>Management Protocol<\/h3>\n <ol>\n <li><strong>Admit to intensive care\/critical care<\/strong><\/li>\n <li>Send urine for Pneumococcal & Legionella antigen<\/li>\n <li>Test for other causes (flu, pulmonary embolism)<\/li>\n <li>Take respiratory culture with appropriate PPE<\/li>\n <li>Take 2 sets of blood cultures, wound cultures<\/li>\n <\/ol>\n\n <div class=\"dosage\">\n <h4>Empiric Antibiotic Treatment<\/h4>\n <p><strong>Standard:<\/strong> Linezolid 600mg bd + Clindamycin 1.2g QDS<\/p>\n <p><strong>Severe disease\/TSS:<\/strong> Add IVIG 2g\/kg + Rifampicin 600mg bd<\/p>\n <\/div>\n\n <h3>If Not Improving<\/h3>\n <ul>\n <li>Check source control and alternative infection sources<\/li>\n <li>Check for other resistant pathogens<\/li>\n <li>Consider 2nd dose of IVIG<\/li>\n <\/ul>\n <\/div>\n\n \n <div id=\"ssti\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing Skin and Soft Tissue Infections<\/h2>\n \n <div class=\"alert-box\">\n <strong>Important:<\/strong> Most PVL Staph aureus in the UK are sensitive to flucloxacillin. Always perform sensitivity tests as per EUCAST, including D test for erythromycin-clindamycin.\n <\/div>\n\n <h3>Minor SSTI<\/h3>\n <p>Furunculosis, folliculitis, small abscesses\/boils without cellulitis<\/p>\n <ul>\n <li><strong>Usually no systemic antibiotics needed<\/strong><\/li>\n <li>Exceptions: immunocompromised, infants, clinical deterioration<\/li>\n <li><span class=\"highlight\">Incision and drainage optimal for abscesses<\/span><\/li>\n <\/ul>\n\n <h3>Moderate SSTI<\/h3>\n <p>Cellulitis and larger abscesses (especially >5cm)<\/p>\n \n <table class=\"treatment-table\">\n <tr>\n <th>Organism<\/th>\n <th>Treatment Options<\/th>\n <\/tr>\n <tr>\n <td>MSSA<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Flucloxacillin 500mg qds<br>\n \u2022 Clindamycin 450mg qds\n <\/div>\n <\/td>\n <\/tr>\n <tr>\n <td>PVL-MRSA (outpatient)<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Rifampicin 300mg bd + Doxycycline 100mg bd<br>\n \u2022 Rifampicin 300mg bd + Fusidic acid 500mg tds<br>\n \u2022 Rifampicin 300mg bd + Trimethoprim 200mg bd<br>\n \u2022 Clindamycin 450mg qds\n <\/div>\n <\/td>\n <\/tr>\n <\/table>\n\n <h3>Severe Infection<\/h3>\n <ul>\n <li>IV vancomycin, teicoplanin, daptomycin, or linezolid<\/li>\n <li>Tigecycline for broader polymicrobial cover (avoid if sepsis signs)<\/li>\n <\/ul>\n\n <h3>Severe with Toxic Shock\/Necrotising Features<\/h3>\n <div class=\"dosage\">\n <strong>Triple therapy:<\/strong><br>\n \u2022 Linezolid 600mg bd<br>\n \u2022 Clindamycin 1.2-1.8g qds<br>\n \u2022 Rifampicin 600mg bd<br>\n \u2022 Surgical debridement<br>\n \u2022 Treat for 10-14 days\n <\/div>\n\n <div class=\"alert-box success\">\n <strong>Rifampicin Benefits:<\/strong> Excellent tissue penetration, reaches intracellular staphylococci, synergistic with other antibiotics including linezolid\n <\/div>\n <\/div>\n\n \n <div id=\"osteomyelitis\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing Osteomyelitis and Deep-Seated Infections<\/h2>\n \n <h3>Investigation<\/h3>\n <ul>\n <li>Blood culture – two sets appropriately filled<\/li>\n <li>Inflammatory markers (WCC, CRP, ESR) and renal\/liver function baseline<\/li>\n <li>Imaging: MRI\/radio-isotope scan<\/li>\n <li>Assess for DVT<\/li>\n <\/ul>\n\n <h3>Treatment Options<\/h3>\n <table class=\"treatment-table\">\n <tr>\n <th>Category<\/th>\n <th>Treatment<\/th>\n <\/tr>\n <tr>\n <td>Preferred<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Teicoplanin 400-800mg IV q24h (after loading dose)<br>\n \u2022 Vancomycin 1g IV q12h<br>\n <strong>PLUS one of:<\/strong><br>\n \u2022 Gentamicin 5-7mg\/kg IV once daily<br>\n \u2022 Rifampicin 300mg PO twice daily<br>\n \u2022 Sodium fusidate 500mg PO thrice daily\n <\/div>\n <\/td>\n <\/tr>\n <tr>\n <td>2nd Choice<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Linezolid 600mg IV\/PO q12h<br>\n \u2022 Daptomycin 6-8mg\/kg IV once daily (off-label)<br>\n \u2022 Tigecycline 100mg loading, then 50mg IV q12h\n <\/div>\n <\/td>\n <\/tr>\n <\/table>\n\n <div class=\"alert-box\">\n <strong>If MSSA confirmed:<\/strong> Use sensitivity-guided agents that inhibit toxin production and have good bone penetration (e.g., Clindamycin + rifampicin or linezolid)\n <\/div>\n\n <div class=\"alert-box danger\">\n <strong>If MRSA positive or unknown:<\/strong> Treat as MRSA regardless\n <\/div>\n\n <h3>Important Considerations<\/h3>\n <ul>\n <li>Hospital assessment likely required with orthopaedic advice<\/li>\n <li>May require prolonged treatment and repeated surgery<\/li>\n <li>Monitor drug levels:\n <ul>\n <li>Teicoplanin trough: 10-20 mg\/L<\/li>\n <li>Vancomycin trough: 10-15 mg\/L<\/li>\n <\/ul>\n <\/li>\n <li><span class=\"highlight\">Linezolid maximum 4 weeks (peripheral neuropathy risk)<\/span><\/li>\n <\/ul>\n <\/div>\n\n \n <div id=\"infection-control\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Infection Control<\/h2>\n \n <h3>Standard Precautions<\/h3>\n <ul>\n <li><strong>Contact precautions<\/strong> (as per MRSA protocol, even for PVL-MSSA)<\/li>\n <li>Single room isolation<\/li>\n <li>Personal protective equipment (plastic apron and gloves)<\/li>\n <li>Meticulous hand hygiene<\/li>\n <li>Environmental cleaning<\/li>\n <\/ul>\n\n <div class=\"alert-box danger\">\n <strong>Necrotising Pneumonia PPE:<\/strong><br>\n Healthcare workers must wear face and eye protection (surgical mask with integral eye protection) during intubation and respiratory care\n <\/div>\n\n <h3>Staff Exposure Protocol<\/h3>\n <p>If staff exposed during aerosol-generating procedure without appropriate PPE:<\/p>\n <ul>\n <li>Screen 3-7 days after exposure<\/li>\n <li>Advise to report symptoms to physician<\/li>\n <li>Managed by occupational health<\/li>\n <\/ul>\n\n <h3>Work Restrictions<\/h3>\n <div class=\"alert-box\">\n <strong>Cannot work in:<\/strong> Nursery, hospital, residential\/care homes, food industry until all lesions healed\n <\/div>\n <p><strong>Other professions:<\/strong> May continue work with infected areas covered by clean, dry dressings<\/p>\n\n <h3>Screening and Decolonisation<\/h3>\n <h4>Primary Case Screening<\/h4>\n <ul>\n <li>Anterior nares and throat swabs<\/li>\n <li>Any suspicious lesions, including damaged skin<\/li>\n <li>Additional sites: perineum, axilla<\/li>\n <\/ul>\n\n <div class=\"dosage\">\n <h4>Decontamination Protocol<\/h4>\n <p><strong>Body wash:<\/strong> Chlorhexidine 4% or Triclosan 2% once daily for 5 days<\/p>\n <p><strong>Nasal:<\/strong> Mupirocin (Bactroban) three times daily for 5 days<\/p>\n <\/div>\n\n <h4>Contact Management<\/h4>\n <ul>\n <li>Close contacts with history of past infection: decolonise without prior screening<\/li>\n <li>Household contacts of necrotising pneumonia: 5-day topical decolonisation immediately<\/li>\n <li>Consider oseltamivir prophylaxis if index case had influenza<\/li>\n <\/ul>\n\n <h3>Notification Requirements<\/h3>\n <ul>\n <li><strong>Hospital cases:<\/strong> Notify infection control<\/li>\n <li><strong>Suspected outbreak:<\/strong> Inform public health<\/li>\n <li><strong>Staff involvement:<\/strong> Notify occupational health<\/li>\n <\/ul>\n <\/div>\n\n \n <div id=\"staff-management\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing Healthcare Staff with PVL-SA<\/h2>\n \n <div class=\"alert-box\">\n <strong>All staff management done via occupational health<\/strong>\n <\/div>\n\n <h3>Active Infection<\/h3>\n <ul>\n <li>HCWs should not work with infected skin or purulent eye lesions<\/li>\n <li>All cuts and grazes must be covered<\/li>\n <li>Report all lesions promptly to Occupational Health Service<\/li>\n <\/ul>\n\n <h3>Return to Work Criteria<\/h3>\n <p>HCW with proven PVL-SA infection should not work until:<\/p>\n <ol>\n <li>Acute infection has resolved<\/li>\n <li>48 hours of five-day decolonisation regimen completed<\/li>\n <\/ol>\n\n <h3>Contact\/Family Management<\/h3>\n <ul>\n <li>Make enquiries in close contact with staff member<\/li>\n <li>Families can be treated simultaneously if required<\/li>\n <\/ul>\n\n <h3>Follow-up Screening<\/h3>\n <ul>\n <li>As per MRSA guidelines: three screens, one week apart<\/li>\n <li><span class=\"highlight\">Re-colonisation may occur from community contact<\/span><\/li>\n <li>Staff must stop working if further skin lesions develop<\/li>\n <\/ul>\n\n <h3>Decolonisation Failure<\/h3>\n <p>If staff remains carrier despite two courses of treatment:<\/p>\n <ul>\n <li>May continue work if not implicated in hospital transmission<\/li>\n <li>Must cease working immediately if infected skin lesion develops<\/li>\n <\/ul>\n\n <h3>Community Activity Restrictions<\/h3>\n <div class=\"alert-box danger\">\n <strong>Avoid until lesions healed:<\/strong><br>\n \u2022 Gyms, saunas, swimming pools<br>\n \u2022 Massage, manicure facilities<br>\n \u2022 Other communal\/recreational settings where lesions cannot be adequately covered\n <\/div>\n <\/div>\n <\/div>\n\n <script>\n function showSection(sectionId) {\n \/\/ Hide navigation\n document.getElementById('navigation').style.display = 'none';\n \n \/\/ Hide all content sections\n const sections = document.querySelectorAll('.content-section');\n sections.forEach(section => {\n section.classList.remove('active');\n });\n \n \/\/ Show selected section\n document.getElementById(sectionId).classList.add('active');\n }\n\n function showNavigation() {\n \/\/ Hide all content sections\n const sections = document.querySelectorAll('.content-section');\n sections.forEach(section => {\n section.classList.remove('active');\n });\n \n \/\/ Show navigation\n document.getElementById('navigation').style.display = 'grid';\n }\n\n \/\/ Add click animations to nav cards\n document.querySelectorAll('.nav-card').forEach(card => {\n card.addEventListener('click', function() {\n this.style.transform = 'scale(0.95)';\n setTimeout(() => {\n this.style.transform = '';\n }, 150);\n });\n });\n <\/script>\n<\/body>\n<\/html>\n<\/blockquote>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Post for academic purposes only. It MUST NOT be used to make a clinical decision. For clinical advice, please discuss […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ngg_post_thumbnail":0,"footnotes":""},"categories":[36],"tags":[76,212,213],"class_list":["post-1129","post","type-post","status-publish","format-standard","hentry","category-bacteria","tag-bacteria","tag-pvl","tag-staph-aureus"],"_links":{"self":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1129"}],"version-history":[{"count":4,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1129\/revisions"}],"predecessor-version":[{"id":1133,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1129\/revisions\/1133"}],"wp:attachment":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

{"id":1129,"date":"2025-07-21T11:21:25","date_gmt":"2025-07-21T10:21:25","guid":{"rendered":"https:\/\/microregistrar.com\/?p=1129"},"modified":"2025-07-21T11:54:16","modified_gmt":"2025-07-21T10:54:16","slug":"pvl-staph-aureus","status":"publish","type":"post","link":"https:\/\/microregistrar.com\/?p=1129","title":{"rendered":"PVL Staph aureus"},"content":{"rendered":"\n

Post for academic purposes only. It MUST NOT be used to make a clinical decision. For clinical advice, please discuss with your doctor.<\/p>\n\n\n\n

\n\n\n\n \n \n PVL Staphylococcus aureus Clinical Guide<\/title>\n <style>\n * {\n margin: 0;\n padding: 0;\n box-sizing: border-box;\n }\n\n body {\n font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\n line-height: 1.6;\n color: #333;\n background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);\n min-height: 100vh;\n }\n\n .container {\n max-width: 1200px;\n margin: 0 auto;\n padding: 20px;\n }\n\n .header {\n background: white;\n border-radius: 15px;\n padding: 30px;\n margin-bottom: 30px;\n box-shadow: 0 10px 30px rgba(0,0,0,0.1);\n text-align: center;\n }\n\n .header h1 {\n color: #2c3e50;\n font-size: 2.5em;\n margin-bottom: 10px;\n }\n\n .stat-box {\n background: #e74c3c;\n color: white;\n padding: 15px;\n border-radius: 10px;\n margin: 20px 0;\n font-weight: bold;\n text-align: center;\n }\n\n .nav-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));\n gap: 20px;\n margin-bottom: 30px;\n }\n\n .nav-card {\n background: white;\n border-radius: 12px;\n padding: 25px;\n cursor: pointer;\n transition: all 0.3s ease;\n box-shadow: 0 5px 15px rgba(0,0,0,0.1);\n border-left: 5px solid #3498db;\n }\n\n .nav-card:hover {\n transform: translateY(-5px);\n box-shadow: 0 15px 30px rgba(0,0,0,0.2);\n border-left-color: #e74c3c;\n }\n\n .nav-card h3 {\n color: #2c3e50;\n margin-bottom: 10px;\n font-size: 1.3em;\n }\n\n .nav-card p {\n color: #7f8c8d;\n font-size: 0.9em;\n }\n\n .content-section {\n display: none;\n background: white;\n border-radius: 15px;\n padding: 30px;\n margin-bottom: 20px;\n box-shadow: 0 10px 30px rgba(0,0,0,0.1);\n animation: fadeIn 0.5s ease-in;\n }\n\n .content-section.active {\n display: block;\n }\n\n @keyframes fadeIn {\n from { opacity: 0; transform: translateY(20px); }\n to { opacity: 1; transform: translateY(0); }\n }\n\n .section-title {\n color: #2c3e50;\n font-size: 2em;\n margin-bottom: 20px;\n border-bottom: 3px solid #3498db;\n padding-bottom: 10px;\n }\n\n .risk-factors {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));\n gap: 15px;\n margin: 20px 0;\n }\n\n .risk-factor {\n background: #f8f9fa;\n padding: 15px;\n border-radius: 8px;\n border-left: 4px solid #e74c3c;\n }\n\n .risk-factor h4 {\n color: #e74c3c;\n margin-bottom: 5px;\n }\n\n .clinical-features {\n display: grid;\n grid-template-columns: 1fr 1fr;\n gap: 25px;\n margin: 20px 0;\n }\n\n .feature-box {\n background: #ecf0f1;\n padding: 20px;\n border-radius: 10px;\n border-top: 4px solid #3498db;\n }\n\n .feature-box h4 {\n color: #2c3e50;\n margin-bottom: 15px;\n font-size: 1.2em;\n }\n\n .treatment-table {\n width: 100%;\n border-collapse: collapse;\n margin: 20px 0;\n background: white;\n border-radius: 8px;\n overflow: hidden;\n box-shadow: 0 5px 15px rgba(0,0,0,0.1);\n }\n\n .treatment-table th {\n background: #3498db;\n color: white;\n padding: 15px;\n text-align: left;\n }\n\n .treatment-table td {\n padding: 12px 15px;\n border-bottom: 1px solid #ecf0f1;\n }\n\n .treatment-table tr:nth-child(even) {\n background: #f8f9fa;\n }\n\n .alert-box {\n background: #fff3cd;\n border: 1px solid #ffeaa7;\n border-radius: 8px;\n padding: 15px;\n margin: 15px 0;\n border-left: 4px solid #f39c12;\n color: #333;\n }\n\n .alert-box.danger {\n background: #f8d7da;\n border-color: #f5c6cb;\n border-left-color: #e74c3c;\n }\n\n .alert-box.success {\n background: #d4edda;\n border-color: #c3e6cb;\n border-left-color: #27ae60;\n }\n\n .back-btn {\n background: #3498db;\n color: white;\n border: none;\n padding: 12px 25px;\n border-radius: 25px;\n cursor: pointer;\n font-size: 1em;\n margin-bottom: 20px;\n transition: all 0.3s ease;\n }\n\n .back-btn:hover {\n background: #2980b9;\n transform: translateY(-2px);\n }\n\n .highlight {\n background: #fff3cd;\n padding: 2px 6px;\n border-radius: 4px;\n font-weight: bold;\n }\n\n .dosage {\n background: #e8f5e8;\n padding: 10px;\n border-radius: 5px;\n margin: 10px 0;\n border-left: 4px solid #27ae60;\n }\n\n ul, ol {\n margin: 15px 0;\n padding-left: 25px;\n }\n\n li {\n margin: 8px 0;\n }\n\n @media (max-width: 768px) {\n .clinical-features {\n grid-template-columns: 1fr;\n }\n \n .nav-grid {\n grid-template-columns: 1fr;\n }\n \n .header h1 {\n font-size: 2em;\n }\n }\n <\/style>\n<\/head>\n<body>\n <div class=\"container\">\n \n <div class=\"header\">\n <p>Clinical Guide for Diagnosis and Management<\/p>\n <div class=\"stat-box\">\n In the UK, PVL genes are carried by < 2% of clinical S. aureus isolates\n <\/div>\n <\/div>\n\n \n <div id=\"navigation\" class=\"nav-grid\">\n <div class=\"nav-card\" onclick=\"showSection('clinical-features')\">\n <h3>\ud83d\udd0d Clinical Features<\/h3>\n <p>Recognize skin\/soft tissue infections and invasive disease presentations<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('risk-factors')\">\n <h3>\u26a0\ufe0f Risk Factors<\/h3>\n <p>5C model and high-risk populations and settings<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('testing')\">\n <h3>\ud83e\uddea Testing & Diagnosis<\/h3>\n <p>Sample collection, processing, and PVL testing protocols<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('pneumonia')\">\n <h3>\ud83e\udec1 Pneumonia Management<\/h3>\n <p>Necrotising pneumonia recognition and treatment protocols<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('ssti')\">\n <h3>\ud83e\ude79 SSTI Management<\/h3>\n <p>Skin and soft tissue infection treatment guidelines<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('osteomyelitis')\">\n <h3>\ud83e\uddb4 Osteomyelitis<\/h3>\n <p>Deep-seated infection management and treatment options<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('infection-control')\">\n <h3>\ud83d\udee1\ufe0f Infection Control<\/h3>\n <p>PPE requirements, isolation, and outbreak management<\/p>\n <\/div>\n <div class=\"nav-card\" onclick=\"showSection('staff-management')\">\n <h3>\ud83d\udc68\u200d\u2695\ufe0f Staff Management<\/h3>\n <p>Healthcare worker screening, decolonisation, and return-to-work<\/p>\n <\/div>\n <\/div>\n\n \n <div id=\"clinical-features\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Clinical Features of PVL-SA<\/h2>\n \n <div class=\"clinical-features\">\n <div class=\"feature-box\">\n <h4>Skin and Soft Tissue Infections<\/h4>\n <ul>\n <li><strong>Suspect when:<\/strong> Recurrent skin and soft tissue infections<\/li>\n <li>Purulent eye infections<\/li>\n <li>Variable size lesions with\/without necrosis<\/li>\n <li><span class=\"highlight\">Pain disproportionate to appearance<\/span><\/li>\n <li>Multiple cases in close contact settings<\/li>\n <\/ul>\n <\/div>\n \n <div class=\"feature-box\">\n <h4>Invasive Infections<\/h4>\n <ul>\n <li><strong>Necrotising pneumonia<\/strong> – may follow flu-like symptoms<\/li>\n <li>Necrotising fasciitis<\/li>\n <li>Purpura fulminans<\/li>\n <li>Acute haematogenous osteomyelitis<\/li>\n <li>Osteoarticular infections in children<\/li>\n <li>Pyomyositis<\/li>\n <\/ul>\n <\/div>\n <\/div>\n\n <div class=\"alert-box danger\">\n <strong>Key Clinical Signs:<\/strong> Haemoptysis and elevated inflammatory markers may accompany necrotising pneumonia\n <\/div>\n <\/div>\n\n \n <div id=\"risk-factors\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Risk Factors for PVL-SA<\/h2>\n \n <div class=\"alert-box\">\n <strong>Remember the 5C Model:<\/strong>\n <\/div>\n \n <div class=\"risk-factors\">\n <div class=\"risk-factor\">\n <h4>Contaminated items<\/h4>\n <p>Shared towels, equipment<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>Close contact<\/h4>\n <p>Direct person-to-person contact<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>Crowding<\/h4>\n <p>Overcrowded living conditions<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>(Lack of) Cleanliness<\/h4>\n <p>Poor hygiene practices<\/p>\n <\/div>\n <div class=\"risk-factor\">\n <h4>Cuts<\/h4>\n <p>Compromised skin integrity<\/p>\n <\/div>\n <\/div>\n\n <h3>High-Risk Settings<\/h3>\n <ul>\n <li>Households<\/li>\n <li>Close contact sports (wrestling, American football, rugby, judo)<\/li>\n <li>Military training camps<\/li>\n <li>Gyms<\/li>\n <li>Prisons<\/li>\n <\/ul>\n\n <div class=\"alert-box success\">\n <strong>Typical Patient Profile:<\/strong> Young, healthy people, students, athletes, and military personnel with no significant medical history\n <\/div>\n <\/div>\n\n \n <div id=\"testing\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Testing for PVL<\/h2>\n \n <h3>Sample Collection<\/h3>\n <ul>\n <li>Wound swab or pus for skin\/soft tissue infections<\/li>\n <li>Sputum\/BAL for respiratory infections<\/li>\n <li>Blood culture for systemic infections<\/li>\n <li>Process samples as per national SMI<\/li>\n <\/ul>\n\n <div class=\"alert-box\">\n <strong>Clinical Hint:<\/strong> If isolate is MRSA and ciprofloxacin sensitive, higher chance of being PVL positive\n <\/div>\n\n <h3>PVL Testing Process<\/h3>\n <ol>\n <li>Grow Staphylococcus aureus from sample<\/li>\n <li>Send isolate to reference laboratory for PVL test<\/li>\n <li>Results guide treatment decisions<\/li>\n <\/ol>\n\n <h3>Outbreak Investigation<\/h3>\n <table class=\"treatment-table\">\n <tr>\n <th>Outbreak Type<\/th>\n <th>Screening Medium<\/th>\n <th>Notes<\/th>\n <\/tr>\n <tr>\n <td>PVL MSSA<\/td>\n <td>Non-selective agar (blood agar)<\/td>\n <td>Standard screening approach<\/td>\n <\/tr>\n <tr>\n <td>PVL MRSA<\/td>\n <td>Selective medium (Mannitol Salt Agar, chromogenic media)<\/td>\n <td>Do NOT use ciprofloxacin for MRSA selection<\/td>\n <\/tr>\n <\/table>\n <\/div>\n\n \n <div id=\"pneumonia\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing PVL Pneumonia<\/h2>\n \n <div class=\"alert-box danger\">\n <strong>Initial Management:<\/strong> Start treatment as per NICE CAP guidelines (NOT the old PVL guideline recommendations)\n <\/div>\n\n <h3>Clinical Suspicion Criteria<\/h3>\n <ul>\n <li>Multilobular infiltrates<\/li>\n <li>Respiratory rate >30, Pulse rate >140<\/li>\n <li>Haemoptysis<\/li>\n <li>Leukopenia \u00b1 skin and soft tissue infection<\/li>\n <li>Young patient<\/li>\n <li>Recent flu-like illness or close contact<\/li>\n <li>High inflammatory markers, raised CK (pyomyositis)<\/li>\n <\/ul>\n\n <h3>Management Protocol<\/h3>\n <ol>\n <li><strong>Admit to intensive care\/critical care<\/strong><\/li>\n <li>Send urine for Pneumococcal & Legionella antigen<\/li>\n <li>Test for other causes (flu, pulmonary embolism)<\/li>\n <li>Take respiratory culture with appropriate PPE<\/li>\n <li>Take 2 sets of blood cultures, wound cultures<\/li>\n <\/ol>\n\n <div class=\"dosage\">\n <h4>Empiric Antibiotic Treatment<\/h4>\n <p><strong>Standard:<\/strong> Linezolid 600mg bd + Clindamycin 1.2g QDS<\/p>\n <p><strong>Severe disease\/TSS:<\/strong> Add IVIG 2g\/kg + Rifampicin 600mg bd<\/p>\n <\/div>\n\n <h3>If Not Improving<\/h3>\n <ul>\n <li>Check source control and alternative infection sources<\/li>\n <li>Check for other resistant pathogens<\/li>\n <li>Consider 2nd dose of IVIG<\/li>\n <\/ul>\n <\/div>\n\n \n <div id=\"ssti\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing Skin and Soft Tissue Infections<\/h2>\n \n <div class=\"alert-box\">\n <strong>Important:<\/strong> Most PVL Staph aureus in the UK are sensitive to flucloxacillin. Always perform sensitivity tests as per EUCAST, including D test for erythromycin-clindamycin.\n <\/div>\n\n <h3>Minor SSTI<\/h3>\n <p>Furunculosis, folliculitis, small abscesses\/boils without cellulitis<\/p>\n <ul>\n <li><strong>Usually no systemic antibiotics needed<\/strong><\/li>\n <li>Exceptions: immunocompromised, infants, clinical deterioration<\/li>\n <li><span class=\"highlight\">Incision and drainage optimal for abscesses<\/span><\/li>\n <\/ul>\n\n <h3>Moderate SSTI<\/h3>\n <p>Cellulitis and larger abscesses (especially >5cm)<\/p>\n \n <table class=\"treatment-table\">\n <tr>\n <th>Organism<\/th>\n <th>Treatment Options<\/th>\n <\/tr>\n <tr>\n <td>MSSA<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Flucloxacillin 500mg qds<br>\n \u2022 Clindamycin 450mg qds\n <\/div>\n <\/td>\n <\/tr>\n <tr>\n <td>PVL-MRSA (outpatient)<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Rifampicin 300mg bd + Doxycycline 100mg bd<br>\n \u2022 Rifampicin 300mg bd + Fusidic acid 500mg tds<br>\n \u2022 Rifampicin 300mg bd + Trimethoprim 200mg bd<br>\n \u2022 Clindamycin 450mg qds\n <\/div>\n <\/td>\n <\/tr>\n <\/table>\n\n <h3>Severe Infection<\/h3>\n <ul>\n <li>IV vancomycin, teicoplanin, daptomycin, or linezolid<\/li>\n <li>Tigecycline for broader polymicrobial cover (avoid if sepsis signs)<\/li>\n <\/ul>\n\n <h3>Severe with Toxic Shock\/Necrotising Features<\/h3>\n <div class=\"dosage\">\n <strong>Triple therapy:<\/strong><br>\n \u2022 Linezolid 600mg bd<br>\n \u2022 Clindamycin 1.2-1.8g qds<br>\n \u2022 Rifampicin 600mg bd<br>\n \u2022 Surgical debridement<br>\n \u2022 Treat for 10-14 days\n <\/div>\n\n <div class=\"alert-box success\">\n <strong>Rifampicin Benefits:<\/strong> Excellent tissue penetration, reaches intracellular staphylococci, synergistic with other antibiotics including linezolid\n <\/div>\n <\/div>\n\n \n <div id=\"osteomyelitis\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing Osteomyelitis and Deep-Seated Infections<\/h2>\n \n <h3>Investigation<\/h3>\n <ul>\n <li>Blood culture – two sets appropriately filled<\/li>\n <li>Inflammatory markers (WCC, CRP, ESR) and renal\/liver function baseline<\/li>\n <li>Imaging: MRI\/radio-isotope scan<\/li>\n <li>Assess for DVT<\/li>\n <\/ul>\n\n <h3>Treatment Options<\/h3>\n <table class=\"treatment-table\">\n <tr>\n <th>Category<\/th>\n <th>Treatment<\/th>\n <\/tr>\n <tr>\n <td>Preferred<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Teicoplanin 400-800mg IV q24h (after loading dose)<br>\n \u2022 Vancomycin 1g IV q12h<br>\n <strong>PLUS one of:<\/strong><br>\n \u2022 Gentamicin 5-7mg\/kg IV once daily<br>\n \u2022 Rifampicin 300mg PO twice daily<br>\n \u2022 Sodium fusidate 500mg PO thrice daily\n <\/div>\n <\/td>\n <\/tr>\n <tr>\n <td>2nd Choice<\/td>\n <td>\n <div class=\"dosage\">\n \u2022 Linezolid 600mg IV\/PO q12h<br>\n \u2022 Daptomycin 6-8mg\/kg IV once daily (off-label)<br>\n \u2022 Tigecycline 100mg loading, then 50mg IV q12h\n <\/div>\n <\/td>\n <\/tr>\n <\/table>\n\n <div class=\"alert-box\">\n <strong>If MSSA confirmed:<\/strong> Use sensitivity-guided agents that inhibit toxin production and have good bone penetration (e.g., Clindamycin + rifampicin or linezolid)\n <\/div>\n\n <div class=\"alert-box danger\">\n <strong>If MRSA positive or unknown:<\/strong> Treat as MRSA regardless\n <\/div>\n\n <h3>Important Considerations<\/h3>\n <ul>\n <li>Hospital assessment likely required with orthopaedic advice<\/li>\n <li>May require prolonged treatment and repeated surgery<\/li>\n <li>Monitor drug levels:\n <ul>\n <li>Teicoplanin trough: 10-20 mg\/L<\/li>\n <li>Vancomycin trough: 10-15 mg\/L<\/li>\n <\/ul>\n <\/li>\n <li><span class=\"highlight\">Linezolid maximum 4 weeks (peripheral neuropathy risk)<\/span><\/li>\n <\/ul>\n <\/div>\n\n \n <div id=\"infection-control\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Infection Control<\/h2>\n \n <h3>Standard Precautions<\/h3>\n <ul>\n <li><strong>Contact precautions<\/strong> (as per MRSA protocol, even for PVL-MSSA)<\/li>\n <li>Single room isolation<\/li>\n <li>Personal protective equipment (plastic apron and gloves)<\/li>\n <li>Meticulous hand hygiene<\/li>\n <li>Environmental cleaning<\/li>\n <\/ul>\n\n <div class=\"alert-box danger\">\n <strong>Necrotising Pneumonia PPE:<\/strong><br>\n Healthcare workers must wear face and eye protection (surgical mask with integral eye protection) during intubation and respiratory care\n <\/div>\n\n <h3>Staff Exposure Protocol<\/h3>\n <p>If staff exposed during aerosol-generating procedure without appropriate PPE:<\/p>\n <ul>\n <li>Screen 3-7 days after exposure<\/li>\n <li>Advise to report symptoms to physician<\/li>\n <li>Managed by occupational health<\/li>\n <\/ul>\n\n <h3>Work Restrictions<\/h3>\n <div class=\"alert-box\">\n <strong>Cannot work in:<\/strong> Nursery, hospital, residential\/care homes, food industry until all lesions healed\n <\/div>\n <p><strong>Other professions:<\/strong> May continue work with infected areas covered by clean, dry dressings<\/p>\n\n <h3>Screening and Decolonisation<\/h3>\n <h4>Primary Case Screening<\/h4>\n <ul>\n <li>Anterior nares and throat swabs<\/li>\n <li>Any suspicious lesions, including damaged skin<\/li>\n <li>Additional sites: perineum, axilla<\/li>\n <\/ul>\n\n <div class=\"dosage\">\n <h4>Decontamination Protocol<\/h4>\n <p><strong>Body wash:<\/strong> Chlorhexidine 4% or Triclosan 2% once daily for 5 days<\/p>\n <p><strong>Nasal:<\/strong> Mupirocin (Bactroban) three times daily for 5 days<\/p>\n <\/div>\n\n <h4>Contact Management<\/h4>\n <ul>\n <li>Close contacts with history of past infection: decolonise without prior screening<\/li>\n <li>Household contacts of necrotising pneumonia: 5-day topical decolonisation immediately<\/li>\n <li>Consider oseltamivir prophylaxis if index case had influenza<\/li>\n <\/ul>\n\n <h3>Notification Requirements<\/h3>\n <ul>\n <li><strong>Hospital cases:<\/strong> Notify infection control<\/li>\n <li><strong>Suspected outbreak:<\/strong> Inform public health<\/li>\n <li><strong>Staff involvement:<\/strong> Notify occupational health<\/li>\n <\/ul>\n <\/div>\n\n \n <div id=\"staff-management\" class=\"content-section\">\n <button class=\"back-btn\" onclick=\"showNavigation()\">\u2190 Back to Menu<\/button>\n <h2 class=\"section-title\">Managing Healthcare Staff with PVL-SA<\/h2>\n \n <div class=\"alert-box\">\n <strong>All staff management done via occupational health<\/strong>\n <\/div>\n\n <h3>Active Infection<\/h3>\n <ul>\n <li>HCWs should not work with infected skin or purulent eye lesions<\/li>\n <li>All cuts and grazes must be covered<\/li>\n <li>Report all lesions promptly to Occupational Health Service<\/li>\n <\/ul>\n\n <h3>Return to Work Criteria<\/h3>\n <p>HCW with proven PVL-SA infection should not work until:<\/p>\n <ol>\n <li>Acute infection has resolved<\/li>\n <li>48 hours of five-day decolonisation regimen completed<\/li>\n <\/ol>\n\n <h3>Contact\/Family Management<\/h3>\n <ul>\n <li>Make enquiries in close contact with staff member<\/li>\n <li>Families can be treated simultaneously if required<\/li>\n <\/ul>\n\n <h3>Follow-up Screening<\/h3>\n <ul>\n <li>As per MRSA guidelines: three screens, one week apart<\/li>\n <li><span class=\"highlight\">Re-colonisation may occur from community contact<\/span><\/li>\n <li>Staff must stop working if further skin lesions develop<\/li>\n <\/ul>\n\n <h3>Decolonisation Failure<\/h3>\n <p>If staff remains carrier despite two courses of treatment:<\/p>\n <ul>\n <li>May continue work if not implicated in hospital transmission<\/li>\n <li>Must cease working immediately if infected skin lesion develops<\/li>\n <\/ul>\n\n <h3>Community Activity Restrictions<\/h3>\n <div class=\"alert-box danger\">\n <strong>Avoid until lesions healed:<\/strong><br>\n \u2022 Gyms, saunas, swimming pools<br>\n \u2022 Massage, manicure facilities<br>\n \u2022 Other communal\/recreational settings where lesions cannot be adequately covered\n <\/div>\n <\/div>\n <\/div>\n\n <script>\n function showSection(sectionId) {\n \/\/ Hide navigation\n document.getElementById('navigation').style.display = 'none';\n \n \/\/ Hide all content sections\n const sections = document.querySelectorAll('.content-section');\n sections.forEach(section => {\n section.classList.remove('active');\n });\n \n \/\/ Show selected section\n document.getElementById(sectionId).classList.add('active');\n }\n\n function showNavigation() {\n \/\/ Hide all content sections\n const sections = document.querySelectorAll('.content-section');\n sections.forEach(section => {\n section.classList.remove('active');\n });\n \n \/\/ Show navigation\n document.getElementById('navigation').style.display = 'grid';\n }\n\n \/\/ Add click animations to nav cards\n document.querySelectorAll('.nav-card').forEach(card => {\n card.addEventListener('click', function() {\n this.style.transform = 'scale(0.95)';\n setTimeout(() => {\n this.style.transform = '';\n }, 150);\n });\n });\n <\/script>\n<\/body>\n<\/html>\n<\/blockquote>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Post for academic purposes only. It MUST NOT be used to make a clinical decision. For clinical advice, please discuss […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ngg_post_thumbnail":0,"footnotes":""},"categories":[36],"tags":[76,212,213],"class_list":["post-1129","post","type-post","status-publish","format-standard","hentry","category-bacteria","tag-bacteria","tag-pvl","tag-staph-aureus"],"_links":{"self":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1129"}],"version-history":[{"count":4,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1129\/revisions"}],"predecessor-version":[{"id":1133,"href":"https:\/\/microregistrar.com\/index.php?rest_route=\/wp\/v2\/posts\/1129\/revisions\/1133"}],"wp:attachment":[{"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1129"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1129"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microregistrar.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}